Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
28
AVCN.TO Quote, Financials, Valuation and Earnings
Last price:
$0.23
Seasonality move
:
-24.92%
Day range:
$0.22 - $0.23
52-week range:
$0.20 - $0.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.01x
P/B ratio:
8.71x
Volume:
31.7K
Avg. volume:
78.8K
1-year change:
-29.23%
Market cap:
$27.1M
Revenue:
$25.5M
EPS (TTM):
-$0.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVCN.TO
Avicanna, Inc.
|
-- | -- | -- | -- | -- |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
DB.V
Decibel Cannabis Co., Inc.
|
$32.7M | -- | 22.08% | -100% | $0.27 |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
WEED.TO
Canopy Growth Corp.
|
$71.8M | -$0.11 | -5.09% | -95.48% | $3.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVCN.TO
Avicanna, Inc.
|
$0.23 | -- | $27.1M | -- | $0.00 | 0% | 1.01x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
DB.V
Decibel Cannabis Co., Inc.
|
$0.11 | $0.27 | $60.6M | 4.18x | $0.00 | 0% | 0.53x |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
WEED.TO
Canopy Growth Corp.
|
$1.84 | $3.76 | $629.6M | -- | $0.00 | 0% | 1.20x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVCN.TO
Avicanna, Inc.
|
-- | 0.032 | -- | 0.34x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
DB.V
Decibel Cannabis Co., Inc.
|
41.86% | 1.065 | 58.78% | 0.53x |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
WEED.TO
Canopy Growth Corp.
|
26.05% | 4.059 | 38.43% | 4.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVCN.TO
Avicanna, Inc.
|
$3.1M | -$1.3M | -17.8% | -17.95% | -19.89% | -$865.2K |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
DB.V
Decibel Cannabis Co., Inc.
|
$4.1M | -$5.4M | 11.03% | 19.6% | -16.27% | $1.5M |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
WEED.TO
Canopy Growth Corp.
|
$16.9M | -$16.4M | -39.84% | -68.7% | -24.59% | -$19.4M |
Avicanna, Inc. vs. Competitors
-
Which has Higher Returns AVCN.TO or COOL.CX?
Core One Labs, Inc. has a net margin of -21.62% compared to Avicanna, Inc.'s net margin of --. Avicanna, Inc.'s return on equity of -17.95% beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AVCN.TOAvicanna, Inc.47.77% -$0.01 $11.7M COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About AVCN.TO or COOL.CX?
Avicanna, Inc. has a consensus price target of --, signalling upside risk potential of 204.35%. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Avicanna, Inc. has higher upside potential than Core One Labs, Inc., analysts believe Avicanna, Inc. is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVCN.TOAvicanna, Inc.0 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is AVCN.TO or COOL.CX More Risky?
Avicanna, Inc. has a beta of 0.270, which suggesting that the stock is 72.99% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock AVCN.TO or COOL.CX?
Avicanna, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avicanna, Inc. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVCN.TO or COOL.CX?
Avicanna, Inc. quarterly revenues are $6.4M, which are larger than Core One Labs, Inc. quarterly revenues of --. Avicanna, Inc.'s net income of -$1.4M is higher than Core One Labs, Inc.'s net income of --. Notably, Avicanna, Inc.'s price-to-earnings ratio is -- while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avicanna, Inc. is 1.01x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVCN.TOAvicanna, Inc.1.01x -- $6.4M -$1.4M COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns AVCN.TO or CURE.X.CX?
Biocure Technology has a net margin of -21.62% compared to Avicanna, Inc.'s net margin of --. Avicanna, Inc.'s return on equity of -17.95% beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AVCN.TOAvicanna, Inc.47.77% -$0.01 $11.7M CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About AVCN.TO or CURE.X.CX?
Avicanna, Inc. has a consensus price target of --, signalling upside risk potential of 204.35%. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Avicanna, Inc. has higher upside potential than Biocure Technology, analysts believe Avicanna, Inc. is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings AVCN.TOAvicanna, Inc.0 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is AVCN.TO or CURE.X.CX More Risky?
Avicanna, Inc. has a beta of 0.270, which suggesting that the stock is 72.99% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AVCN.TO or CURE.X.CX?
Avicanna, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avicanna, Inc. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVCN.TO or CURE.X.CX?
Avicanna, Inc. quarterly revenues are $6.4M, which are larger than Biocure Technology quarterly revenues of --. Avicanna, Inc.'s net income of -$1.4M is higher than Biocure Technology's net income of --. Notably, Avicanna, Inc.'s price-to-earnings ratio is -- while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avicanna, Inc. is 1.01x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVCN.TOAvicanna, Inc.1.01x -- $6.4M -$1.4M CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns AVCN.TO or DB.V?
Decibel Cannabis Co., Inc. has a net margin of -21.62% compared to Avicanna, Inc.'s net margin of -4.07%. Avicanna, Inc.'s return on equity of -17.95% beat Decibel Cannabis Co., Inc.'s return on equity of 19.6%.
Company Gross Margin Earnings Per Share Invested Capital AVCN.TOAvicanna, Inc.47.77% -$0.01 $11.7M DB.VDecibel Cannabis Co., Inc.12.53% -$0.00 $109.4M -
What do Analysts Say About AVCN.TO or DB.V?
Avicanna, Inc. has a consensus price target of --, signalling upside risk potential of 204.35%. On the other hand Decibel Cannabis Co., Inc. has an analysts' consensus of $0.27 which suggests that it could grow by 153.97%. Given that Avicanna, Inc. has higher upside potential than Decibel Cannabis Co., Inc., analysts believe Avicanna, Inc. is more attractive than Decibel Cannabis Co., Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVCN.TOAvicanna, Inc.0 0 0 DB.VDecibel Cannabis Co., Inc.3 0 0 -
Is AVCN.TO or DB.V More Risky?
Avicanna, Inc. has a beta of 0.270, which suggesting that the stock is 72.99% less volatile than S&P 500. In comparison Decibel Cannabis Co., Inc. has a beta of 0.460, suggesting its less volatile than the S&P 500 by 53.973%.
-
Which is a Better Dividend Stock AVCN.TO or DB.V?
Avicanna, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Decibel Cannabis Co., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avicanna, Inc. pays -- of its earnings as a dividend. Decibel Cannabis Co., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVCN.TO or DB.V?
Avicanna, Inc. quarterly revenues are $6.4M, which are smaller than Decibel Cannabis Co., Inc. quarterly revenues of $32.9M. Avicanna, Inc.'s net income of -$1.4M is lower than Decibel Cannabis Co., Inc.'s net income of -$1.3M. Notably, Avicanna, Inc.'s price-to-earnings ratio is -- while Decibel Cannabis Co., Inc.'s PE ratio is 4.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avicanna, Inc. is 1.01x versus 0.53x for Decibel Cannabis Co., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVCN.TOAvicanna, Inc.1.01x -- $6.4M -$1.4M DB.VDecibel Cannabis Co., Inc.0.53x 4.18x $32.9M -$1.3M
-
Which has Higher Returns AVCN.TO or HEAL.CX?
has a net margin of -21.62% compared to Avicanna, Inc.'s net margin of --. Avicanna, Inc.'s return on equity of -17.95% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AVCN.TOAvicanna, Inc.47.77% -$0.01 $11.7M HEAL.CX-- -- -- -
What do Analysts Say About AVCN.TO or HEAL.CX?
Avicanna, Inc. has a consensus price target of --, signalling upside risk potential of 204.35%. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Avicanna, Inc. has higher upside potential than , analysts believe Avicanna, Inc. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings AVCN.TOAvicanna, Inc.0 0 0 HEAL.CX0 0 0 -
Is AVCN.TO or HEAL.CX More Risky?
Avicanna, Inc. has a beta of 0.270, which suggesting that the stock is 72.99% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AVCN.TO or HEAL.CX?
Avicanna, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avicanna, Inc. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVCN.TO or HEAL.CX?
Avicanna, Inc. quarterly revenues are $6.4M, which are larger than quarterly revenues of --. Avicanna, Inc.'s net income of -$1.4M is higher than 's net income of --. Notably, Avicanna, Inc.'s price-to-earnings ratio is -- while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avicanna, Inc. is 1.01x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVCN.TOAvicanna, Inc.1.01x -- $6.4M -$1.4M HEAL.CX-- -- -- --
-
Which has Higher Returns AVCN.TO or WEED.TO?
Canopy Growth Corp. has a net margin of -21.62% compared to Avicanna, Inc.'s net margin of -2.46%. Avicanna, Inc.'s return on equity of -17.95% beat Canopy Growth Corp.'s return on equity of -68.7%.
Company Gross Margin Earnings Per Share Invested Capital AVCN.TOAvicanna, Inc.47.77% -$0.01 $11.7M WEED.TOCanopy Growth Corp.25.3% -$0.01 $995.3M -
What do Analysts Say About AVCN.TO or WEED.TO?
Avicanna, Inc. has a consensus price target of --, signalling upside risk potential of 204.35%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 104.35%. Given that Avicanna, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Avicanna, Inc. is more attractive than Canopy Growth Corp..
Company Buy Ratings Hold Ratings Sell Ratings AVCN.TOAvicanna, Inc.0 0 0 WEED.TOCanopy Growth Corp.1 4 1 -
Is AVCN.TO or WEED.TO More Risky?
Avicanna, Inc. has a beta of 0.270, which suggesting that the stock is 72.99% less volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.
-
Which is a Better Dividend Stock AVCN.TO or WEED.TO?
Avicanna, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avicanna, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVCN.TO or WEED.TO?
Avicanna, Inc. quarterly revenues are $6.4M, which are smaller than Canopy Growth Corp. quarterly revenues of $66.7M. Avicanna, Inc.'s net income of -$1.4M is higher than Canopy Growth Corp.'s net income of -$1.6M. Notably, Avicanna, Inc.'s price-to-earnings ratio is -- while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avicanna, Inc. is 1.01x versus 1.20x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVCN.TOAvicanna, Inc.1.01x -- $6.4M -$1.4M WEED.TOCanopy Growth Corp.1.20x -- $66.7M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
